Nephrology Dialysis Transplantation,
Journal Year:
2014,
Volume and Issue:
30(6), P. 924 - 933
Published: Sept. 4, 2014
Recent
studies
have
highlighted
the
close
relationship
between
kidney
and
gastrointestinal
(GI)
tract—frequently
referred
to
as
kidney–gut
axis—in
patients
with
chronic
disease
(CKD).
In
this
regard,
two
important
pathophysiological
concepts
evolved:
(i)
production
accumulation
of
toxic
end-products
derived
from
increased
bacterial
fermentation
protein
other
nitrogen-containing
substances
in
GI
tract,
(ii)
translocation
endotoxins
live
bacteria
gut
lumen
into
bloodstream,
due
damage
intestinal
epithelial
barrier
quantitative/qualitative
alterations
microbiota
associated
uraemic
milieu.
both
cases,
these
gut-centred
may
relevant
systemic
consequences
CKD
patients,
since
they
are
able
trigger
inflammation,
increase
cardiovascular
risk
worsen
toxicity.
The
present
review
is
thus
focused
on
axis
CKD,
special
attention
local
(i.e.
collection
microorganisms
living
a
symbiotic
coexistence
their
host
lumen)
relationships
inflammation
toxicity
CKD.
Moreover,
we
will
summarize
most
clinical
data
suggesting
potential
for
nutritional
modulation
gut-related
noxious
by-products
contributing
patients.
Nature Communications,
Journal Year:
2018,
Volume and Issue:
9(1)
Published: Aug. 13, 2018
Accumulating
evidence
implicates
metabolites
produced
by
gut
microbes
as
crucial
mediators
of
diet-induced
host-microbial
cross-talk.
Here,
we
review
emerging
data
suggesting
that
microbial
tryptophan
catabolites
resulting
from
proteolysis
are
influencing
host
health.
These
suggested
to
activate
the
immune
system
through
binding
aryl
hydrocarbon
receptor
(AHR),
enhance
intestinal
epithelial
barrier,
stimulate
gastrointestinal
motility,
well
secretion
hormones,
exert
anti-inflammatory,
anti-oxidative
or
toxic
effects
in
systemic
circulation,
and
putatively
modulate
composition.
Tryptophan
thus
affect
various
physiological
processes
may
contribute
homeostasis
health
disease.
World Journal of Gastroenterology,
Journal Year:
2016,
Volume and Issue:
22(2), P. 501 - 501
Published: Jan. 1, 2016
The
gut
microbiota
acts
as
a
real
organ.The
symbiotic
interactions
between
resident
micro-organisms
and
the
digestive
tract
highly
contribute
to
maintain
homeostasis.However,
alterations
microbiome
caused
by
environmental
changes
(e.g.
,
infection,
diet
and/or
lifestyle)
can
disturb
this
relationship
promote
disease,
such
inflammatory
bowel
diseases
cancer.Colorectal
cancer
is
complex
association
of
tumoral
cells,
non-neoplastic
cells
large
amount
micro-organisms,
involvement
in
colorectal
carcinogenesis
becoming
increasingly
clear.Indeed,
many
bacterial
composition
have
been
reported
cancer,
suggesting
major
role
dysbiosis
carcinogenesis.Some
species
identified
suspected
play
carcinogenesis,
Streptococcus
bovis
Helicobacter
pylori
Bacteroides
Gut,
Journal Year:
2012,
Volume and Issue:
62(11), P. 1591 - 1601
Published: Dec. 12, 2012
Objective
Antibiotic
(AB)
usage
strongly
affects
microbial
intestinal
metabolism
and
thereby
impacts
human
health.
Understanding
this
process
the
underlying
mechanisms
remains
a
major
research
goal.
Accordingly,
we
conducted
first
comparative
omic
investigation
of
gut
communities
in
faecal
samples
taken
at
multiple
time
points
from
an
individual
subjected
to
β-lactam
therapy.
Methods
The
total
(16S
rDNA)
active
rRNA)
microbiota,
metagenome,
metatranscriptome
(mRNAs),
metametabolome
(high-performance
liquid
chromatography
coupled
electrospray
ionisation
quadrupole
time-of-flight
mass
spectrometry)
metaproteome
(ultra
high
performing
Orbitrap
MS2
instrument
[UPLC-LTQ
Orbitrap-MS/MS])
patient
undergoing
AB
therapy
for
14
days
were
evaluated.
Results
Apparently
oscillatory
population
dynamics
observed,
with
early
reduction
Gram-negative
organisms
(day
6)
overall
collapse
diversity
possible
further
colonisation
by
‘presumptive’
naturally
resistant
bacteria
11),
followed
re-growth
Gram-positive
species
14).
During
process,
maximum
imbalance
fraction
occurred
later
14)
than
greatest
change
fraction,
which
reached
minimum
biodiversity
richness
on
day
11;
additionally,
metabolic
changes
6.
Gut
respond
ABs
activating
systems
avoid
antimicrobial
effects
drugs,
while
‘presumptively’
attenuating
their
energetic
status
capacity
transport
metabolise
bile
acid,
cholesterol,
hormones
vitamins;
host–microbial
interactions
significantly
improved
after
treatment
cessation.
Conclusions
This
proof-of-concept
study
provides
extensive
description
microbiota
responses
follow-up
results
demonstrate
that
targeting
specific
pathogenic
infections
diseases
may
alter
ecology
host
much
higher
level
previously
assumed.
Cell Reports,
Journal Year:
2014,
Volume and Issue:
9(4), P. 1202 - 1208
Published: Nov. 1, 2014
It
has
long
been
speculated
that
metabolites,
produced
by
gut
microbiota,
influence
host
metabolism
in
health
and
diseases.
Here,
we
reveal
indole,
a
metabolite
from
the
dissimilation
of
tryptophan,
is
able
to
modulate
secretion
glucagon-like
peptide-1
(GLP-1)
immortalized
primary
mouse
colonic
L
cells.
Indole
increased
GLP-1
release
during
short
exposures,
but
it
reduced
over
longer
periods.
These
effects
were
attributed
ability
indole
affect
two
key
molecular
mechanisms
On
one
hand,
inhibited
voltage-gated
K+
channels,
temporal
width
action
potentials
fired
cells,
led
enhanced
Ca2+
entry,
thereby
acutely
stimulating
secretion.
other
slowed
ATP
production
blocking
NADH
dehydrogenase,
thus
leading
prolonged
reduction
Our
results
identify
as
signaling
molecule
which
microbiota
communicate
with
cells
metabolism.
Journal of Gastroenterology and Hepatology,
Journal Year:
2013,
Volume and Issue:
28(S4), P. 9 - 17
Published: Nov. 19, 2013
Abstract
The
human
gastrointestinal
tract
harbors
trillions
of
bacteria,
most
which
are
commensal
and
have
adapted
over
time
to
the
milieu
colon.
Their
many
metabolic
interactions
with
each
other,
host,
influence
nutrition
metabolism
in
diverse
ways.
Our
understanding
these
influences
has
come
through
breakthroughs
molecular
profiling
phylogeny
capacities
microbiota.
gut
microbiota
produce
a
variety
nutrients
including
short‐chain
fatty
acids,
B
vitamins,
vitamin
K
.
Because
their
ability
interact
receptors
on
epithelial
cells
subepithelial
cells,
also
release
number
cellular
factors
that
metabolism.
Thus,
they
potential
roles
pathogenesis
syndrome,
diabetes,
non‐alcoholic
liver
disease,
cognition,
extend
well
beyond
traditional
contribution
nutrition.
This
review
explores
metabolism,
putative
mechanisms
underlying
effects.
European Journal of Nutrition,
Journal Year:
2018,
Volume and Issue:
57(S1), P. 1 - 14
Published: May 1, 2018
The
2017
annual
symposium
organized
by
the
University
Medical
Center
Groningen
in
Netherlands
focused
on
role
of
gut
microbiome
human
health
and
disease.
Experts
from
academia
industry
examined
interactions
prebiotics,
probiotics,
or
vitamins
with
disease,
development
early-life
gut-brain
axis.
microbiota
changes
dramatically
during
pregnancy
intrinsic
factors
(such
as
stress),
addition
to
extrinsic
diet,
drugs)
influence
composition
activity
throughout
life.
Microbial
metabolites,
e.g.
short-chain
fatty
acids
affect
signaling
immune
response.
has
a
regulatory
anxiety,
mood,
cognition
pain
which
is
exerted
via
Ingestion
prebiotics
probiotics
been
used
treat
range
conditions
including
constipation,
allergic
reactions
infections
infancy,
IBS.
Fecal
transplantation
(FMT)
highly
effective
for
treating
recurrent
Clostridium
difficile
infections.
affects
virtually
all
aspects
health,
but
degree
scientific
evidence,
models
technologies
understanding
mechanisms
action
vary
considerably
one
benefit
area
other.
For
clinical
practice
be
broadly
accepted,
mode
action,
therapeutic
window,
potential
side
effects
need
thoroughly
investigated.
This
calls
further
coordinated
state-of-the
art
research
better
understand
document
microbiome's
health.